Accelerating diagnosis of Parkinson’s disease through risk prediction

Abstract

Overall, our machine learning approach allows for both guiding clinical decisions such as the initiation of neuroprotective interventions and importantly, the possibility of earlier diagnosis for clinical trials for disease modifying therapies.